AMONDYS 45 (CASIMERSEN)
Live / Registered — Registered (as of 16 Nov 2021)
What this means for you
Registered since 16 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90458567
- Registration number
- 6564415
- Mark type
- Design + words
- Filed
- 11 Jan 2021
- Published for opposition
- 27 Jul 2021
- Registered
- 16 Nov 2021
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations featuring antisense oligonucleotides, for the treatment of neuromuscular diseases and disorders
Owner
- Sarepta Therapeutics, Inc., Cambridge, MA, US
- Sarepta Therapeutics, Inc., Cambridge, MA, US
- Sarepta Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 16 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 13 Oct 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Oct 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Oct 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Sept 2021 — USE AMENDMENT FILED
- 12 Oct 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Sept 2021 — TEAS STATEMENT OF USE RECEIVED
- 21 Sept 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Jul 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Jul 2021 — PUBLISHED FOR OPPOSITION
- 07 Jul 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jun 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jun 2021 — EXAMINER'S AMENDMENT ENTERED
- 24 Jun 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 24 Jun 2021 — EXAMINERS AMENDMENT E-MAILED